In its 2021 strategy report, the Global Initiative for Chronic Obstructive Lung Disease
states:“we no longer refer to asthma-COPD overlap (ACO), instead we emphasize that …

Topical glucocorticoids are a well-known risk factor of intraocular pressure (IOP) elevation in
one third of the general population and in up to 90% of glaucomatous patients. Whether this …

Objectives: Describe the epidemiology of steroid-induced glaucoma. Review the
presentation of a patient with steroid-induced glaucoma. Summarize the treatment options …

Purpose We aimed to explore the effect of multiple pre‐and postnatal exposures on optic
nerve status in young adults due to this critical period for development. Methods We …

Purpose Guidelines and systematic reviews frequently warn of inhaled corticosteroid (ICS)-
induced glaucoma. However, most of the published studies deny it. Methods We performed …

Purpose Starting in 2019, the Global Initiative for Asthma recommended the use of inhaled
corticosteroids (ICS) as part of reliever combination therapy in patients 12 years of age and …

Based on 2015 data obtained from the Global Burden of Disease Study, around 36 million
people in the world or the global population are blind, 12.6 million of them are caused by …

Secondary childhood glaucoma can be associated with non-acquired disorders (ocular or
systemic) or acquired conditions. Pediatric cataract surgery is a vital etiology that leads to …

Uveitis is the fifth leading cause of blindness in developed countries [1, 2]. Epidemiological
data show that uveitis currently affects over 2 million people worldwide [3]. According to data …

Zapalenia błony naczyniowej (ZBN) są piątą przyczyną ślepoty w krajach rozwiniętych.
Pojawiające się powikłania miejscowe w ich przebiegu są wynikiem nie tylko samego …